Evidence map›Paper›PMID 30923443›Full record

ReviewFood technology and biotechnology2018

The Role of Vitamin D in Inflammatory Bowel Disease - Assessing Therapeutic and Preventive Potential of Supplementation and Food Fortification.

Dunja Leskovar, Tomislav Meštrović, Anja Barešić, Ivana Kraljević, Marina Panek, Hana Čipčić Paljetak, Mihaela Perić, Mario Matijašić, Dunja Rogić, Ana Barišić and 4 more

Open access · diamondAbstract readReview
In one paragraph

Review in Food technology and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Patterns of vitamin D testing and supplementation for children with inflammatory bowel disease in Australasia.JGH open : an open access journal of gastroenterology and hepatology · 2024
    Article
  4. La Tunisie medicale · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Dunja LeskovarUniversity of Zagreb School of Medicine, Šalata 3, 10 000 Zagreb, Croatia.ORCID 0000-0002-2342-4450
Tomislav MeštrovićPolyclinic "Dr. Zora Profozić", Bosutska 19, 10 000 Zagreb, Croatia.ORCID 0000-0002-8751-8149
Anja BarešićMRC London Institute of Medical Sciences, Du Cane Rd, London W12 0NN, United Kingdom.
Ivana KraljevićUniversity Hospital Centre, Kišpatićeva 12, 10 000 Zagreb, Croatia.ORCID 0000-0002-4379-2250
Marina PanekUniversity of Zagreb School of Medicine, Šalata 3, 10 000 Zagreb, Croatia.ORCID 0000-0003-3045-1235
Hana Čipčić PaljetakUniversity of Zagreb School of Medicine, Šalata 3, 10 000 Zagreb, Croatia.
Mihaela PerićUniversity of Zagreb School of Medicine, Šalata 3, 10 000 Zagreb, Croatia.ORCID 0000-0002-1904-2193
Mario MatijašićUniversity of Zagreb School of Medicine, Šalata 3, 10 000 Zagreb, Croatia.ORCID 0000-0001-9209-4611
Dunja RogićUniversity Hospital Centre, Kišpatićeva 12, 10 000 Zagreb, Croatia.ORCID 0000-0001-7097-276X
Ana BarišićUniversity Hospital Centre, Kišpatićeva 12, 10 000 Zagreb, Croatia.ORCID 0000-0003-1419-6967
Dina Ljubas KelečićUniversity Hospital Centre, Kišpatićeva 12, 10 000 Zagreb, Croatia.ORCID 0000-0003-4310-7580
Darija Vranešić BenderUniversity Hospital Centre, Kišpatićeva 12, 10 000 Zagreb, Croatia.ORCID 0000-0001-7153-4753
Željko KrznarićUniversity Hospital Centre, Kišpatićeva 12, 10 000 Zagreb, Croatia.ORCID 0000-0003-3758-4540
Donatella VerbanacUniversity of Zagreb School of Medicine, Šalata 3, 10 000 Zagreb, Croatia.ORCID 0000-0002-9106-1604
University Hospital Centre Zagreb · HRUniversity of Zagreb · HRMRC London Institute of Medical Sciences · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel diseases are a group of chronic inflammatory conditions that affect gastrointestinal tract due to inapt and continuous immune activation in response to a myriad of predisposing factors (most notably genetics, environmental impact and gut microbiota composition). It has been shown that vitamin D status can also play a role in the disease pathogenesis, as its deficiency is commonly observed in two major forms of inflammatory bowel diseases - Crohn's disease and ulcerative colitis. Mounting evidence supports the concept of intricate relationship between gut dysbiosis and vitamin D metabolism, while suboptimal levels of this vitamin have been linked to increased clinical disease relapse rates, inadequate response to drugs, as well as decreased quality of life in patients with Crohn's disease and ulcerative colitis. Consequently, the pertinent question is whether increased vitamin D supplementation and (on a population level) food fortification may bring significant benefit to the affected individuals. In this short review we discuss the synthesis, functions, status and food sources of vitamin D, appraise biotechnological facets of vitamin D status analysis and food fortification, and concentrate on novel developments in the field that describe its influence on intestinal microbiota and inflammatory bowel disease.

Indexed as

Crohn’s diseasedysbiosisgut microbiotainflammatory bowel diseasesulcerative colitisvitamin D

Identifiers

PMID30923443
PMCPMC6399717
OpenAlexW2903026945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.